Wednesday, 23 May 2018

Teva hopes to launch migraine drug as soon as September

JERUSALEM (Reuters) - Teva Pharmaceutical Industries said on Wednesday it could launch its migraine treatment as soon as mid-September, after an initial delay.


No comments:

Post a Comment